| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Agah Ramtin is a Chief Medical Officer at RenovoRx, Inc.. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $703K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 10,000 | $1.00 | $9,975.00 | +1.3% | - | - | |
| Dec 31, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 9,795 | $0.86 | $8,423.70 | +1.3% | +20.2% | - | |
| Dec 30, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 205 | $0.83 | $169.33 | - | +22.3% | - | |
| Dec 16, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 12,000 | $0.85 | $10,200.00 | +1.6% | +15.5% | - | |
| Dec 5, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 10,000 | $0.96 | $9,600.00 | +1.3% | -12.7% | - | |
| Nov 24, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 22,000 | $0.80 | $17,600.00 | +1.5% | +14.8% | - | |
| Jun 5, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 21,000 | $1.40 | $29,400.00 | +2.9% | -10.7% | -37.7% | |
| Apr 15, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 15,000 | $0.90 | $13,500.00 | +1.4% | +55.6% | +9.5% | |
| Apr 11, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 20,000 | $0.80 | $16,000.00 | +1.9% | +73.6% | +27.6% | |
| Apr 9, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 30,000 | $0.81 | $24,399.00 | +2.9% | +56.6% | +17.8% |